Bio-Rad Laboratories (NYSE:BIO) reported first-quarter 2026 results that fell within its revenue guidance range, while management emphasized that geopolitical disruption in the Middle East and continu ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K. Lakkaraju ...
3don MSN
Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption
Q1 2026 Management View Jonathan DiVincenzo (President & COO) said Bio-Rad “reported Q1 results within our revenue guidance” while facing “several external pressures, most notably associated with the ...
Aug. 20, 2024 8:30 AM ETBio-Rad Laboratories, Inc. (BIO), BIO.B "We are thrilled to welcome Jon DiVincenzo as our President and Chief Operating Officer,” stated Norman Schwartz, Bio-Rad’s Chairman and ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Jon DiVincenzo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results